Analysis of induced sputum in refractory asthma;Analyse de l'expectoration induite dans l'asthme réfractaire

Presse Medicale

Volumn 37, Issue 1 II, 2008, Pages 155-159

  Louis, Renaud ^a   Potmans, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; NITRIC OXIDE; SALBUTAMOL; SODIUM CHLORIDE; TRIAMCINOLONE;

ASTHMA; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; EOSINOPHIL; EOSINOPHILIA; HUMAN; NEUTROPHILIA; NON INVASIVE PROCEDURE; PATIENT SAFETY; PHENOTYPE; SHORT SURVEY; SPUTUM ANALYSIS;

EID: 37349076519     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.05.033     Document Type: Short Survey

References (34)

1. Djukanovic R., Roche W.R., Wilson J.W., Beasley C.R., Twentyman O.P., Howarth R.H., et al. Mucosal inflammation in asthma. Am Rev Respir Dis 142 (1990) 434-457
2. Pin I., Gibson P.G., Kolendowicz R., Girgis-Gabardo A., Denburg J.A., Hargreave F.E., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47 (1992) 25-29
3. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-51.
4. Popov T.A., Pizzichini M.M., Pizzichini E., Kolendowicz R., Punthakee Z., Dolovich J., et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J 8 (1995) 559-565
5. Ten Brinke A., de Lange C., Zwinderman A.H., Rabe K.F., Sterk P.J., and Bel E.H. Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstriction. Am J Respir Crit Care Med 164 (2001) 749-753
6. Delvaux M., Henket M., Lau L., Kange P., Bartsch P., Djukanovic R., et al. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 59 (2004) 111-115
7. Vlachos-Mayer H., Leigh R., Sharon R.F., Hussack P., and Hargreave F.E. Success and safety of sputum induction in the clinical setting. Eur Respir J 16 (2000) 997-1000
8. Louis R., Sele J., Henket M., Cataldo D., Bettiol J., Seiden L., et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 57 (2002) 907-912
9. de la Fuente P.T., Romagnoli M., Godard P., Bousquet J., and Chanez P. Safety of inducing sputum in patients with asthma of varying severity. Am J Respir Crit Care Med 157 (1998) 1127-1130
10. In't Veen J.C.C.M., de Gouw W., Smits H.H., Sont J.K., Hiemstra P.S., Sterk P.J., et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 9 (1996) 2441-2447
11. Holz O., Richter K., Jorres R.A., Speckin P., Mucke M., and Magnussen H. Changes in sputum composition between two inductions performed on consecutive days. Thorax 53 (1998) 83-86
12. Holz O., Jorres R.A., Koschyk S., Speckin P., Welker L., and Magnussen H. Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy 28 (1998) 284-292
13. Fahy J.V. A safe, simple, standardized method should be used for sputum induction for research purposes. Clin Exp Allergy 28 (1998) 1047-1049
14. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., and Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161 (2000) 9-16
15. Jatakanon A., Lalloo U.G., Lim S., Chung K.F., and Barnes P.J. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 54 (1999) 234-237
16. Wark P.A., Saltos N., Simpson J., Slater S., Hensley M.J., and Gibson P.G. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 16 (2000) 1095-1101
17. Green R.H., Brightling C.E., Woltmann G., Parker D., Wardlaw A.J., and Pavord I.D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57 (2002) 875-879
18. O'Donnell R.A., and Frew A.J. Is there more than one inflammatory phenotype in asthma?. Thorax 57 (2002) 566-568
19. Simpson J.L., Grissell T.V., Douwes J., Scott R.J., Boyle M.J., and Gibson P.G. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62 (2007) 211-218
20. Pizzichini M.M., Pizzichini E., Clelland L., Efthimiadis A., Pavord I., Dolovich J., et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 13 (1999) 15-21
21. Jatakanon A., Lim S., and Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161 (2000) 64-72
22. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
23. Jayaram L., Pizzichini M.M., Cook R.J., Boulet L.P., Lemiere C., Pizzichini E., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 (2006) 483-494
24. Ten Brinke A., Zwinderman A.H., Sterk P.J., Rabe K.F., and Bel E.H. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 170 (2004) 601-605
25. Kharitonov S.A., Gonio F., Kelly C., Meah S., and Barnes P.J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 21 (2003) 433-438
26. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., and Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 (1998) 91-95
27. Van Rensen E.L., Straathof K.C., Veselic-Charvat M.A., Zwinderman A.H., Bel E.H., and Sterk P.J. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54 (1999) 403-408
28. Silkoff P.E., Lent A.M., Busacker A.A., Katial R.K., Balzar S., Strand M., et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 116 (2005) 1249-1255
29. Verleden G.M., Dupont L.J., Verpeut A.C., and Demedts M.G. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest 116 (1999) 59-64
30. Berry M.A., Shaw D.E., Green R.H., Brightling C.E., Wardlaw A.J., and Pavord I.D. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy 35 (2005) 1175-1179
31. Lemiere C., Ernst P., Olivenstein R., Yamauchi Y., Govindaraju K., Ludwig M.S., et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 118 (2006) 1033-1039
32. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
33. Deykin A., Lazarus S.C., Fahy J.V., Wechsler M.E., Boushey H.A., Chinchilli V.M., et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 115 (2005) 720-727
34. Leuppi J.D., Salome C.M., Jenkins C.R., Anderson S.D., Xuan W., Marks G.B., et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 163 (2001) 406-412